Suppr超能文献

肿瘤浸润中性粒细胞和腺体形成可预测胰腺导管腺癌的总生存期和分子亚群。

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma.

机构信息

Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, BC, Canada.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

出版信息

Cancer Med. 2021 Feb;10(3):1155-1165. doi: 10.1002/cam4.3695. Epub 2020 Dec 28.

Abstract

BACKGROUND

RNA-sequencing-based classifiers can stratify pancreatic ductal adenocarcinoma (PDAC) into prognostically significant subgroups but are not practical for use in clinical workflows. Here, we assess whether histomorphological features may be used as surrogate markers for predicting molecular subgroup and overall survival in PDAC.

METHODS

Ninety-six tissue samples from 50 patients with non-resectable PDAC were scored for gland formation, stromal maturity, mucin, necrosis, and neutrophil infiltration. Prognostic PDAC gene expression classifiers were run on all tumors using whole transcriptome sequencing data from the POG trial (NCT02155621). Findings were validated using digital TCGA slides (n = 50). Survival analysis used multivariate Cox proportional-hazards tests and log-rank tests.

RESULTS

The combination of low gland formation and low neutrophil infiltration was significantly associated with the poor prognosis PDAC molecular subgroup (basal-like or squamous) and was an independent predictor of shorter overall survival, in both frozen section (n = 47) and formalin-fixed paraffin-embedded (n = 49) tissue samples from POG patients, and in the TCGA samples. This finding held true in the subgroup analysis of primary (n = 17) and metastatic samples (n = 79). The combination of high gland formation and high neutrophils had low sensitivity but high specificity for favorable prognosis subgroups.

CONCLUSIONS

The assessment of gland formation and neutrophil infiltration on routine histological sections can aid in prognostication and allow inferences to be made about molecular subtype, which may help guide patient management decisions and contribute to our understanding of heterogeneity in treatment response.

摘要

背景

基于 RNA 测序的分类器可以将胰腺导管腺癌 (PDAC) 分为具有显著预后意义的亚组,但不适用于临床工作流程。在这里,我们评估组织形态学特征是否可作为预测 PDAC 分子亚组和总体生存的替代标志物。

方法

对 50 名不可切除 PDAC 患者的 96 个组织样本进行评分,以评估腺体形成、基质成熟度、黏液、坏死和中性粒细胞浸润。使用来自 POG 试验(NCT02155621)的全转录组测序数据对所有肿瘤进行预后 PDAC 基因表达分类器分析。使用数字 TCGA 幻灯片(n=50)验证发现。使用多变量 Cox 比例风险测试和对数秩检验进行生存分析。

结果

低腺体形成和低中性粒细胞浸润的组合与预后不良的 PDAC 分子亚组(基底样或鳞状)显著相关,是 POG 患者冷冻切片(n=47)和福尔马林固定石蜡包埋(n=49)组织样本以及 TCGA 样本中总生存期较短的独立预测因子。这一发现适用于原发(n=17)和转移样本(n=79)的亚组分析。高腺体形成和高中性粒细胞的组合对预后良好的亚组具有低敏感性但高特异性。

结论

在常规组织学切片上评估腺体形成和中性粒细胞浸润有助于预后判断,并可对分子亚型进行推断,这可能有助于指导患者管理决策,并有助于我们了解治疗反应的异质性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b33/7897949/3d40b09d4fcc/CAM4-10-1155-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验